← Open Payments lookup

JUAN ANGEL: Open Payments

NPI 1811475213 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,042 in 99 payments from 17 companies in 2025. Trend: 2023 $1,366 · 2024 $1,972 · 2025 $3,042

Food & beverage: $2,943Education: $99
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$532
Regeneron Healthcare Solutions, Inc.15$494
GENZYME CORPORATION11$344
GlaxoSmithKline, LLC.18$318
Optinose US, Inc.2$277
ARS Pharmaceuticals Operations, Inc.4$208
Genentech USA, Inc.5$186
Genentech, Inc.1$139
Novartis Pharmaceuticals Corporation5$139
Takeda Pharmaceuticals U.S.A., Inc.6$139

Products named: DUPIXENT, TEZSPIRE, Xolair, Xhance, NUCALA, NEFFY, AIRSUPRA, CUVITRU.

Industry payments across FL — which companies pay providers there.